$AIMD

TSAI CHUN-JUNG sold $2K of AIMD

TSAI CHUN-JUNG sold 1,082 shares of Ainos, Inc. (AIMD) at $1.55 on 2026-05-22.

Original reporting
SEC EDGAR · TSAI CHUN-JUNG
Published May 27, 2026, 11:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 12:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIMD
Neutral
medium confidence
Mentioned
$AIMD
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIMDNeutralMed
01

Why it matters

Insider selling can pressure sentiment, especially for small-cap names, but the filing lacks any fundamental trigger (no earnings, trial, contract, or deal).

02

Market read

Traders may watch for follow-on insider activity or unusual volume, but this alone is not a fundamental catalyst.

03

What to watch

No 10b5-1 plan is cited, so traders may over-interpret intent; also, the remaining holdings (685,917 shares) suggest continued insider exposure.

Relevance 7/10Timing: Immediate (new SEC Form 4 disclosure dated 2026-05-27 for a sale on 2026-05-22).

Background

The article is an SEC Form 4 insider transaction disclosure for Ainos, Inc. (AIMD).

Company-level read

Ticker impact

$AIMDNeutralMedium confidence
Context

SEC Form 4 shows director TSAI CHUN-JUNG sold 1,082 shares of Ainos, Inc. (AIMD) in an open-market transaction at $1.55.

Expected impact

Likely modest negative/neutral short-term drift; magnitude uncertain because it’s a small, single-insider sale with no 10b5-1 plan noted.

Evidence & confidence

The filing is a disclosed insider sale (not a buy) and can affect sentiment, but the article provides no earnings, guidance, or fundamental change.

Market effects

Minimal—this is company-specific insider activity with no sector-wide catalyst mentioned.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio management; without a stated reason, it may not reflect bearish fundamentals.

Key entities

  • Ainos, Inc.

    Subject of the SEC Form 4 insider sale disclosure.

  • TSAI CHUN-JUNG

    Director who sold 1,082 shares of AIMD at $1.55/share.

Related articles

$AIMDLow

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced resu

$AIMDMed

Ainos, Inc.: VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Ainos, Inc. (NASDAQ:AIMD) said VASRO GmbH highlighted its AI Nose platform’s expansion into live emergency department operations. VASRO reports a research program at an Asia academic medical center to generate 2,500+ hours of emergency-department environmental scent data for overcrowding early warning and respiratory infection risk analysis. The initiative broadens evaluations beyond industrial settings and supports Ainos’ Smell Language Model development.